Zdrowie i gospodarka · 15/07/2020

FDA Announces Final Guidance for Clinical Investigations of Prostate Tissue Ablation Devices

The Food and Drug Administration (FDA) has released a final guidance document outlining recommendations for clinical trials of high-intensity ultrasound systems and new prostate tissue ablation devices, aimed at improving the safety and efficacy of these medical devices.